TCRR Annual Working Capital
$113.56 M
-$143.96 M-55.90%
31 December 2022
Summary:
As of February 5, 2025, TCRR annual working capital is $113.56 million, with the most recent change of -$143.96 million (-55.90%) on December 31, 2022. During the last 3 years, it has fallen by -$42.09 million (-27.04%).TCRR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TCRR Quarterly Working Capital
$93.02 M
-$20.54 M-18.09%
31 March 2023
Summary:
As of February 5, 2025, TCRR quarterly working capital is $93.02 million, with the most recent change of -$20.54 million (-18.09%) on March 31, 2023. Over the past year, it has dropped by -$123.42 million (-57.02%).TCRR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TCRR Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -55.9% | -57.0% |
| 3 y3 years | -27.0% | -26.7% |
| 5 y5 years | +483.2% | - |
TCRR Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -55.9% | -72.0% |
TCR2 Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $93.02 M(-18.1%) |
| Dec 2022 | $113.56 M(-55.9%) | $113.56 M(-23.0%) |
| Sept 2022 | - | $147.39 M(-16.9%) |
| June 2022 | - | $177.26 M(-18.1%) |
| Mar 2022 | - | $216.44 M(-16.0%) |
| Dec 2021 | $257.52 M(+13.6%) | $257.52 M(-10.2%) |
| Sept 2021 | - | $286.70 M(-7.6%) |
| June 2021 | - | $310.28 M(-6.7%) |
| Mar 2021 | - | $332.45 M(+46.6%) |
| Dec 2020 | $226.70 M | $226.70 M(-8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $246.38 M(+93.4%) |
| June 2020 | - | $127.42 M(+0.5%) |
| Mar 2020 | - | $126.83 M(-18.5%) |
| Dec 2019 | $155.65 M(+29.7%) | $155.65 M(-1.9%) |
| Sept 2019 | - | $158.73 M(-5.8%) |
| June 2019 | - | $168.52 M(+5.2%) |
| Mar 2019 | - | $160.23 M(+33.5%) |
| Dec 2018 | $120.03 M(+516.4%) | $120.03 M(-5.9%) |
| Sept 2018 | - | $127.60 M(+555.3%) |
| Dec 2017 | $19.47 M(+19.1%) | $19.47 M |
| Dec 2016 | $16.35 M | - |
FAQ
- What is TCR2 Therapeutics annual working capital?
- What is the all time high annual working capital for TCR2 Therapeutics?
- What is TCR2 Therapeutics annual working capital year-on-year change?
- What is TCR2 Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for TCR2 Therapeutics?
- What is TCR2 Therapeutics quarterly working capital year-on-year change?
What is TCR2 Therapeutics annual working capital?
The current annual working capital of TCRR is $113.56 M
What is the all time high annual working capital for TCR2 Therapeutics?
TCR2 Therapeutics all-time high annual working capital is $257.52 M
What is TCR2 Therapeutics annual working capital year-on-year change?
Over the past year, TCRR annual working capital has changed by -$143.96 M (-55.90%)
What is TCR2 Therapeutics quarterly working capital?
The current quarterly working capital of TCRR is $93.02 M
What is the all time high quarterly working capital for TCR2 Therapeutics?
TCR2 Therapeutics all-time high quarterly working capital is $332.45 M
What is TCR2 Therapeutics quarterly working capital year-on-year change?
Over the past year, TCRR quarterly working capital has changed by -$123.42 M (-57.02%)